Literature DB >> 2575872

In vitro drug sensitivity of Trypanosoma gambiense isolates.

R Brun1, S Baeriswyl, C Kunz.   

Abstract

Drug sensitivities of seven Trypanosoma b. gambiense isolates from patients in the Ivory Coast were measured for Mel B, suramin and lomidine using an in vitro incorporation test. Bloodstream forms were isolated from Mastomys natalensis, incubated in serial drug dilutions in a microtiter plate, after 24 h, radiolabeled hypoxanthine was added, and the plate incubated for another 15 h. Trypanosomes were then harvested onto glass fiber filters with a cell harvester and incorporation of label was determined in a liquid scintillation counter. From the incorporation inhibition curves IC50 and IC75 values were calculated. IC50 values for Mel B ranged from 0.5 to 4.6 ng/ml, for suramin from 7.2 to 30.5 micrograms/ml, and for lomidine from 2.1 to 7.0 ng/ml. Isolate TH-1/78E(031) was the least sensitive to all three drugs while TH-1/78E(020), TH-64/78E(020) and TH-31/78E(025) were the most sensitive to the drugs used. THDAL 1030R, an isolate from a patient who relapsed after three consecutive Mel B treatments, showed an IC50 value for Mel B of 1.20 ng/ml. The in vitro drug sensitivity test gave reproducible results for the T b. gambiense isolates tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575872     DOI: 10.1016/0001-706x(89)90049-1

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  3 in total

1.  A new photometric assay for testing trypanocidal activity in vitro.

Authors:  J Zinsstag; R Brun; M Gessler
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  In vitro drug sensitivity of Trypanosoma congolense isolates.

Authors:  R Brun; S Rab
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Luminescent multiplex viability assay for Trypanosoma brucei gambiense.

Authors:  Nick Van Reet; Pati Pyana; Stijn Rogé; Filip Claes; Philippe Büscher
Journal:  Parasit Vectors       Date:  2013-07-15       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.